ERBB2 and breast cancer: The Kaplan-Meier curves (Figure 3) demonstrate that breast cancer patients aged ≥60 years, ER-negative, PR-negative, HER2-negative, and those with triple-negative molecular subtype exhibited significantly lower overall survival rates (all P < 0.001).